Vincent Madison

6.6k citations

97 papers · 4.7k indexed · h-index 40

Impact in

Molecular Biology top 2%
- Chemical Synthesis and Analysis
- Protein Structure and Dynamics
- RNA and protein synthesis mechanisms
Spectroscopy top 1%
- Molecular spectroscopy and chirality

Papers in

Hepatology 19
- Hepatitis C virus research 19
Spectroscopy 14

Co-authors: John A. Schellman Elkan Blout Charles M. Deber Kenneth D. Kopple C. Chandra Kumar Norma G. Delaney Robert E. Palermo Shigetoshi Oiki
Journals: Biopolymers (16 papers)Bioorganic & Medicinal Chemistry Letters (11 papers)Journal of Medicinal Chemistry (11 papers)Journal of the American Chemical Society (10 papers)Biochemistry (8 papers)
Partner nations: United States Switzerland United Kingdom

In The Last Decade

Vincent Madison

96 papers receiving 4.4k citations

Peers

Countries citing papers authored by Vincent Madison

Since Specialization

Citations

This map shows the geographic impact of Vincent Madison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Madison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Madison more than expected).

Fields of papers citing papers by Vincent Madison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Madison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Madison. The network helps show where Vincent Madison may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Vincent Madison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vincent Madison Line = papers co-authored together Vincent Madison links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitor Bioorganic & Medicinal Chemistry Letters ·Yongqi Deng, Gerald W. Shipps, Lianyun Zhao, M. Arshad Siddiqui, Janeta Popovici-Müller, R.B. Goldberg, José S. Duca, Alan Hruza, Thierry Fischmann, Vincent Madison, Rumin Zhang, Charles McNemar, Todd Mayhood, Rosalinda Syto, Davey Smith, Paul T. Kirschmeier, Emma Lees, David Parry, William T. Windsor	2013	17
2	Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 1 Bioorganic & Medicinal Chemistry Letters ·Michael P. Dwyer, Kamil Paruch, Marc Labroli, Carmen Álvarez, Kerry Keertikar, Lasha Bobokhidze, Randall R. Rossman, Thierry Fischmann, José S. Duca, Vincent Madison, David Parry, Nicole R. Davis, Wolfgang Seghezzi, Derek Wiswell, Timothy J. Guzi	2010	55
3	Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 2 Bioorganic & Medicinal Chemistry Letters ·Marc Labroli, Kamil Paruch, Michael P. Dwyer, Carmen Álvarez, Giselle Geddes, Lasha Bobokhidze, Randall R. Rossman, José S. Duca, Thierry Fischmann, Vincent Madison, David Parry, Nicole R. Davis, Wolfgang Seghezzi, Derek Wiswell, Timothy J. Guzi	2010	62
4	Potent ketoamide inhibitors of HCV NS3 protease derived from quaternized P1 groups Bioorganic & Medicinal Chemistry Letters ·Srikanth Venkatraman, Francisco Velázquez, Wanli Wu, Melissa L. Blackman, Vincent Madison, F. George Njoroge	2010	16
5	Discovery of novel hydroxamates as highly potent tumor necrosis factor-α converting enzyme inhibitors. Part II: Optimization of the S3′ pocket Bioorganic & Medicinal Chemistry Letters ·Robert Mazzola, Zhaoning Zhu, Stephen Austin Chigozie, Brian A. McKittrick, Brian J. Lavey, A. H. Ayoub, Joseph A. Kozlowski, Hameed K. Al-Salmani حميد خلف السلماني, Guowei Zhou, Zhuyan Guo, Peter Orth, Vincent Madison, Ya. Gorbunova, Daniel Lundell, Xiaoda Niu	2008	28
6	Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability Protein Engineering Design and Selection ·Wei Wang, Rachel Bearden, Jing Chen, S. Shane Taremi, Hoang V. Le, Vincent Madison, Xiaona Cui, Ann Thomas, Kui Cheng, Charles A. Lesburg	2008	49
7	Crystal Structures of the Pro-Inflammatory Cytokine Interleukin-23 and Its Complex with a High-Affinity Neutralizing Antibody Journal of Molecular Biology ·Brian M. Beyer, Richard Ingram, Lata Ramanathan, Paul Reichert, Hung V. Le, Vincent Madison, Peter Orth	2008	48
8	Structure‐guided discovery of cyclin‐dependent kinase inhibitors Biopolymers ·Thierry Fischmann, Alan Hruza, José S. Duca, Lata Ramanathan, Todd Mayhood, William T. Windsor, Hung V. Le, Timothy J. Guzi, Michael P. Dwyer, Kamil Paruch, Ronald J. Doll, Emma Lees, David Parry, Wolfgang Seghezzi, Vincent Madison	2007	46
9	P2–P4 Macrocyclic inhibitors of hepatitis C virus NS3-4A serine protease Bioorganic & Medicinal Chemistry Letters ·Ashok Arasappan, F. George Njoroge, Kevin X. Chen, Srikanth Venkatraman, N. Ouakkasse, Yana Keck, John Pichardo, Nancy Butkiewicz, Andrew Prongay, Vincent Madison, Viyyoor Girijavallabhan	2006	16
10	Stabilization of the autoproteolysis of TNF-alpha converting enzyme (TACE) results in a novel crystal form suitable for structure-based drug design studies Protein Engineering Design and Selection ·Richard Ingram, Peter Orth, Corey L. Strickland, Hung V. Le, Vincent Madison, Brian M. Beyer	2006	24
11	Proline‐Based Macrocyclic Inhibitors of the Hepatitis C Virus: Stereoselective Synthesis and Biological Activity Angewandte Chemie International Edition ·Kevin X. Chen, F. George Njoroge, Bancha Vibulbhan, Andrew Prongay, John Pichardo, Vincent Madison, Alexei V. Buevich, Tze‐Ming Chan	2005	10
12	Crystal Structure of the Catalytic Domain of Human ADAM33 Journal of Molecular Biology ·Peter Orth, Paul Reichert, Wenyan Wang, W.W. Prosise, T. Yarosh-Tomaine, Gerald Hammond, Richard Ingram, Li Xiao, Urooj A. Mirza, Jun Zou, Corey L. Strickland, S. Shane Taremi, Hung V. Le, Vincent Madison	2003	66
13	Insights from a Three-Dimensional Model into Ligand Binding to Constitutive Active Receptor Drug Metabolism and Disposition ·Li Xiao, Xiaoming Cui, Vincent Madison, Ronald E. White, Kui Cheng	2002	28
14	Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules Nature Biotechnology ·Fiorenza Falcioni, Kouichi Ito, Damir Vidović, Charles Belunis, Robert M. Campbell, Steven J. Berthel, David Bolin, I Bandinelli, Nicholas Huby, Gary L. Olson, Ramakanth Sarabu, Jeanmarie Guenot, Vincent Madison, Jürgen Hammer, Francesco Sinigaglia, Michael Steinmetz, Zoltan A. Nagy	1999	49
15	Peptide Mimetics of Thyrotropin-Releasing Hormone Based on a Cyclohexane Framework: Design, Synthesis, and Cognition-Enhancing Properties Journal of Medicinal Chemistry ·Gary L. Olson, Herbert C. Cheung, Philipe Lopes Cantreva, Vincent Madison, Jcruss Mitwirkung, Akira Nmakaoka, Andrew Winokur, Keith A. Gary	1995	47
16	Insertion of a Structural Domain of Interleukin (IL)-1β Confers Agonist Activity to the IL-1 Receptor Antagonist Journal of Biological Chemistry ·Scott Greenfeder, 大西正俊, Gordon Powers, K. Kobanawa, David J. Shuster, Kim W. McIntyre, Dene E. Ryan, Wayne Levin, Vincent Madison, G Ju	1995	26
17	Solution structures of cyclic and dicyclic analogues of growth hormone releasing factor as determined by two‐dimensional NMR and CD spectroscopies and constrained molecular dynamics Biopolymers ·David C. Fry, Vincent Madison, 貴豊梅本, A. Felix, Edgar P. Heimer, Lawrence A. Frohman, Robert M. Campbell, Thomas F. Mowles, V. Toome, B. Wegrzynski	1992	28
18	Bundles of amphipathic transmembrane α‐helices as a structural motif for ion‐conducting channel proteins: Studies on sodium channels and acetylcholine receptors Proteins Structure Function and Bioinformatics ·Shigetoshi Oiki, Vincent Madison, M Montal	1990	65
19	Three-dimensional structure of porcine C5adesArg from proton nuclear magnetic resonance data Biochemistry ·Michael P. Williamson, Vincent Madison	1990	39
20	Synthesis, biological activity and conformational analysis of cyclic GRF analogs International journal of peptide & protein research ·A. Felix, Edgar P. Heimer, João Francisco Santos da Silva I, Theodore Lambros, Alain Fournier, Thomas F. Mowles, Mona Atef, Robert M. Campbell, B. Wegrzynski, V. Toome, David C. Fry, Vincent Madison	1988	174

About Vincent Madison

Vincent Madison is a scholar working on Hepatology, Spectroscopy, Molecular Biology, Infectious Diseases and Organic Chemistry, having authored 97 papers that have together received 4.7k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (25 papers), Hepatitis C virus research (19 papers), HIV/AIDS drug development and treatment (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Carbohydrate Chemistry and Synthesis (10 papers), Protein Structure and Dynamics (8 papers), Enzyme Structure and Function (8 papers) and Biochemical and Molecular Research (7 papers). The work is most often cited by research in Molecular Biology (3.2k citations), Spectroscopy (667 citations), Organic Chemistry (1.0k citations), Computational Theory and Mathematics (331 citations) and Microbiology (127 citations). Vincent Madison has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include John A. Schellman, Elkan Blout, Charles M. Deber, Kenneth D. Kopple, C. Chandra Kumar, Norma G. Delaney, Robert E. Palermo, Shigetoshi Oiki, David C. Fry and José S. Duca. Their work appears in journals such as Biopolymers, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of the American Chemical Society and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact